Benzoylgomisin O has been shown to have cytotoxic activity against cancer cells in vitro and has been investigated for the treatment of nervous system diseases. Benzoylgomisin O has been shown to modulate the expression of genes related to cell proliferation and apoptosis, both in vitro and in vivo. This product can be used for research in the fields of medicine and pharmacy.
Molecular Weight
520.57
Molecular Formula
C30H32O8
Form
Solid
Purity
≥98%, determined by HPLC.
Applications
Benzoylgomisin O can be used for research in the fields of medicine and pharmacy.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.